Showing results (651-660 of 828) with videos related to

Sort By:
Pageof 83
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2018
Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral NeuropathyDaniel L Hertz, Kelley M Kidwell, Kiran Vangipuram, et al.
The Pharmacogenomics Journal|May 8, 2009
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patientsJ M Rae, M J Sikora, N L Henry, et al.
Breast Cancer Research and Treatment|January 21, 2009
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohortN Lynn Henry, James M Rae, Lang Li, et al.
Pediatric Obesity|November 1, 2018
Home and neighbourhood built environment features in family-based treatment for childhood obesityJ F Hayes, K N Balantekin, R P K Conlon, et al.
Nature Medicine|December 1, 1996
Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cellsC D Gimmi, B W Morrison, B A Mainprice, et al.
Breast Cancer Research and Treatment|September 13, 2005
Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapyAnne F Schott, Marilyn A Roubidoux, Mark A Helvie, et al.
Pharmacogenomics|July 24, 2020
Genetic variation in Charcot-Marie-Tooth genes contributes to sensitivity to paclitaxel-induced peripheral neuropathyYongzhen Chen, Fang Fang, Kelley M Kidwell, et al.
Annals of Emergency Medicine|May 2, 2025
Formative Evaluation to Inform Implementation of Sepsis Bundles in Emergency DepartmentsHannah E Frank, Nima Sarani, Jacqueline F Hayes, et al.
Breast Cancer Research and Treatment|February 13, 2019
Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletionLandry K Kamdem, Jingyue Xi, Brandi L Clark, et al.
Pageof 83